Adamas Pharmaceuticals (ADMS)
US Market

Adamas Pharmaceuticals (ADMS) Stock Price & Analysis


ADMS Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$4.02 - $9.15
Previous Close$8.22
Average Volume (3M)951.98K
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)-4.8
Next EarningsN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.70
Shares OutstandingN/A
10 Day Avg. Volume964,775
30 Day Avg. Volume1,146,939
Standard DeviationN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside2.19% Upside
Rating ConsensusHold
Number of Analyst Covering7

Adamas Pharmaceuticals News

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Adamas Pharmaceuticals’s price range in the past 12 months?
Adamas Pharmaceuticals lowest stock price was $4.02 and its highest was $9.15 in the past 12 months.
    What is Adamas Pharmaceuticals’s market cap?
    Adamas Pharmaceuticals’s market cap is 376.37M.
      When is Adamas Pharmaceuticals’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Adamas Pharmaceuticals’s earnings last quarter?
      Currently, no data Available
      Is Adamas Pharmaceuticals overvalued?
      According to Wall Street analysts Adamas Pharmaceuticals’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does Adamas Pharmaceuticals pay dividends?
        Adamas Pharmaceuticals does not currently pay dividends.
        What is Adamas Pharmaceuticals’s EPS estimate?
        Adamas Pharmaceuticals’s EPS estimate is -1.7.
          How many shares outstanding does Adamas Pharmaceuticals have?
          Adamas Pharmaceuticals has 45,790,000 shares outstanding.
            What happened to Adamas Pharmaceuticals’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Adamas Pharmaceuticals?
            Among the largest hedge funds holding Adamas Pharmaceuticals’s share is Fisher Asset Management LLC. It holds Adamas Pharmaceuticals’s shares valued at N/A.


              Adamas Pharmaceuticals Stock Smart Score

              The Adamas Pharmaceuticals stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
              Learn more about TipRanks Smart Score

              Company Description

              Adamas Pharmaceuticals

              Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. GOCOVRI is indicated for the treatment of dyskinesia in patients with Parkinson's disease receiving levodopa-based therapy. ADS-5102 is a treatment for walking impairment in patients with multiple sclerosis. ADS-401 treats partial onset seizures in patients with epilepsy. Namzaric is a drug treatment for moderate to severe Alzheimer's disease. The company was founded by Gregory T. Went on November 15, 2000 and is headquartered in Emeryville, CA.


              Forecast EPS vs Actual EPS

              Currently, no data available
              Please return soon. This page is being updated.

              Similar Stocks
              Price & Change
              Acorda Therapeutics
              Merck & Company
              H Lundbeck
              ACADIA Pharmaceuticals

              Popular Stocks

              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis